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Multidrug-resistant Enterococcus faecalis possess numerous mo-
bile elements that encode virulence and antibiotic resistance traits
as well as new metabolic pathways, often constituting over one-
quarter of the genome. It was of interest to determine how this
large accretion of mobile elements affects competitive growth in
the gastrointestinal (GI) tract consortium. We unexpectedly ob-
served that the prototype clinical isolate strain V583 was actively
killed by GI tract flora, whereas commensal enterococci flourished.
It was found that killing of V583 resulted from lethal cross-talk
between accumulated mobile elements and that this cross-talk
was induced by a heptapeptide pheromone produced by native
E. faecalis present in the fecal consortium. These results highlight
two important aspects of the evolution of multidrug-resistant en-
terococci: (i) the accretion of mobile elements in E. faecalis V583
renders it incompatible with commensal strains, and (ii) because of
this incompatibility, multidrug-resistant strains sharing features
found in V583 cannot coexist with commensal strains. The accu-
mulation of mobile elements in hospital isolates of enterococci can
include those that are inherently incompatible with native flora,
highlighting the importance of maintaining commensal popula-
tions as means of preventing colonization and subsequent infec-
tion by multidrug-resistant strains.
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The human gastrointestinal (GI) tract is a highly competitiveenvironment colonized by a diverse microbial population (1).
Diversity is shaped by factors such as vertical transmission, im-
mune selection, diet, and other influences, including antibiotic
therapy (2–4). Enterococci are ancient members of GI tract
consortia of everything from humans to insects (5–7). Commensal
enterococci have reduced genomes (∼2.7 Mb) (8) and despite
their success in this highly competitive environment, possess
auxotrophies for amino acids, vitamins, and other micronutrients
(9). Paralleling the broad application of antibiotics in healthcare
and animal husbandry, multidrug-resistant (MDR) enterococci
emerged as leading causes of hospital infection (7, 10, 11). Ap-
proximately one-third are now vancomycin-resistant (VRE) (6).
Genomes of pathogenic MDR enterococci are replete with mo-
bile genetic elements (8, 11). Enterococcus faecalis V583, the first
VRE Enterococcus isolated in the United States (12), is additionally
resistant to high levels of aminoglycosides, macrolides, lincosamides,
and streptograms B and has an enlarged 3.36-Mb genome that in-
cludes six plasmids or plasmid-like elements (three integrated into
the chromosome), seven prophages, and numerous other insertions
(ISs), including a 138-kb pathogenicity island (PAI), transposons,
and 38 IS elements (13, 14). This accumulation contrasts sharply
with OG1RF, a well-characterized, commensal-like oral isolate (15,
16) that has a 2.7-Mb genome containing only a prophage previously
identified as being ubiquitous in the species (17) and a remnant of a
nonantibiotic resistance transposon of unknown functionality (18).
Hospital-adapted MDR E. faecalis isolates generally lack a func-
tional clustered regularly interspaced short palindromic repeats lo-
cus, which seems to have facilitated mobile element accretion (19).
MDR enterococci colonize the patient after perturbation of
the native flora by antibiotic treatment, including therapies with
little or no antienterococcal activity (6, 20–22). The E. faecalis
V583 PAI and other mobile elements confer the ability to pro-
duce new virulence factors, produce colonization traits, and use
novel metabolites (14). This observation raises the question as to
whether pathogenic MDR enterococci occupy the same micro-
niche as native commensal enterococci (20).
At minimum, the simple maintenance of ∼600 kb of foreign
DNA on mobile elements in V583 (13) would be predicted to
impose a burden in a highly competitive environment where
there is no offsetting antibiotic selection. We hypothesized that
some or most of these mobile elements were obtained in an
uncompetitive antibiotic-affected environment, resulting in little
penalty for an accompanying fitness cost. If true, the large
complement of mobile DNA in V583 could compromise its ability
to proliferate in a competitive, native GI tract consortium and
possibly, fundamentally alter its interaction with other members of
that consortium. To determine whether E. faecalis V583 behaved
in ways different from a commensal strain (using for comparison
the commensal-like nonantibiotic-resistant OG1), we compared
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their growth in the presence of healthy human fecal flora under a
number of conditions. Not only did the healthy flora inhibit V583
(and not OG1), but the fecal consortium actively killed the MDR
strain. With a view toward limiting the outgrowth of VRE in the
GI tract of hospitalized patients, we determined the basis for
this antagonism.
Results
MDR E. faecalis V583 Is Killed When Cultured with Healthy Human
Flora. To determine whether MDR V583 was compromised in
its ability to compete among healthy human GI tract flora, we
compared its growth with that of model commensal OG1X [a
sister clone of OG1RF that possesses a selectable streptomycin
resistance marker (15)]. To simulate environmental cues and
carbon sources that may occur in the GI tract (23), we developed
an M9 minimal salts-based medium (24) that included 1% crude
hog gastric mucin (HGM9; Sigma). Fig. 1 shows that, in HGM9
monoculture, either V583 (Fig. 1A) or OG1X proliferates (Fig.
1B). However, healthy flora derived from pooled human fecal
samples imposed competitive limitation on each one.
To probe the relationship between the E. faecalis being com-
pared and members of the fecal consortium, various carbohydrates
were added, including some utilizable by E. faecalis and others
utilizable only by members of the fecal consortium. These carbo-
hydrates included N-acetylneuraminic acid, D-fucose, D-galac-
tosamine, D-panose, D-galactose, GalNAc, and as a control,
D-glucose. To our surprise, we observed the active, selective killing
of MDR V583 but not OG1X in HGM9 to which glucose, N-ace-
tylgalactosamine, galactose, or panose had been added (Fig. 1).
This killing was observed, despite the fact that V583 grew well in
monoculture in the presence of these carbon sources. In contrast,
OG1X was observed to grow under all coculture conditions (Fig.
1B). This result was interpreted to mean that glucose, GalNAc,
galactose, and panose increased the abundance of flora antago-
nistic to V583 or that these sugars selectively altered the metabo-
lism of V583 (and not OG1X), rendering it susceptible to killing.
Loss of Commensal Enterococci from the Fecal Consortium Correlates
with Loss of V583 Killing. In an attempt to enrich or deplete a pu-
tative V583 antagonist from the fecal consortium, we pretreated
the consortium for 24 h with either erythromycin or tetracycline
(Fig. 2). Erythromycin eliminated the galactose-enhanced V583
antagonism (Fig. 2A), which correlated with the loss of native en-
terococci from the fecal consortium (Fig. 2B). In contrast, V583
killing by the fecal consortium was unaffected and even enhanced,
such that it no longer required galactose augmentation by tetra-
cycline treatment (Fig. 2C), conditions that also enriched the native
enterococci in the fecal consortium (Fig. 2D).
Because measures that inhibit native enterococci in the flora
reduce V583 inhibition and measures that increase native entero-
coccal numbers enhance V583 inhibition and because bacteriocin
production by enterococci is common and well-known (25), we
selectively plated the GI tract flora onto Bile Esculin Azide agar
with tetracycline to isolate implicated, potentially bacteriocin-pro-
ducing, tetracycline-resistant enterococcal strain(s) resident within
the consortium. The colonies obtained were uniform, and a rep-
resentative colony was chosen for additional study. It was found by
16S sequencing to be E. faecalis and termed strain Pan7. Pan7 and
as controls, the well-characterized E. faecalis laboratory strains
OG1X (15) and FA2-2 (26) [sequenced plasmid-free strains that
represent diverse points across the species phylogeny (17); both
were not previously known to express bacteriocin activity] were
spotted onto soft agar lawns of V583. Fig. 2E shows zones of in-
hibition around Pan7 and surprisingly, controls as well. If the V583
inhibition observed was bacteriocin-dependent, it was because of a
previously unreported activity expressed by all E. faecalis strains
tested. E. faecalis susceptibility to class IIa bacteriocins involves
RpoN-dependent expression of a mannose phosphotransferase
system operon (27, 28). To determine whether V583 sensitivity to
E. faecalis inhibition was RpoN-dependent, V583ΔrpoN (29) was
tested for resistance to Pan7-mediated inhibition. It was observed
to be as sensitive as WT V583 (Fig. 2F), indicating that suscepti-
bility was unrelated to the RpoN-dependent mechanism.
Genetic Basis for V583 Susceptibility to Killing. To determine why
V583 was inhibited by commensal E. faecalis but OG1RF and
other strains were not, we examined differences between their
genomes. As noted, V583 harbors ∼600 kb mobile element DNA
that is absent from OG1RF (16, 18). The largest V583 mobile
element is the 138-kb PAI (13, 14). We recently reported the
generation of OG1RF/V583 hybrids possessing from 285 to 858 kb
of V583 chromosomal DNA, including the PAI and flanking
sequences that encompass it (30), in the OG1RF background. To
test whether susceptibility to killing was encoded by the PAI or the
considerable length of V583 sequence on either side, E. faecalis
Pan7 was spotted onto soft agar lawns containing V583 or hybrids
Tc3 (an OG1RF hybrid possessing the V583 PAI plus 147 kb of
additional flanking V583 sequence) or Tc12 (an OG1RF hybrid
that harbors the PAI plus an additional 720 kb of flanking V583
genome sequence) (30). As shown in Fig. 3A, neither the PAI nor
the large portions of V583 chromosomal DNA surrounding it
confer sensitivity to Pan7-mediated killing.
Other mobile elements unique to V583 include its plasmids. A
plasmid-cured derivative, V19 (31), was tested. Unlike V583,
V19 grew well in coculture with Pan7 (Fig. 3B). This result im-
plicated the involvement of one or more plasmids in the V583
susceptibility phenotype. Therefore, plasmids pTEF1 and pTEF2
Fig. 1. Pathogenic but not commensal E. faecalis are killed in fecal con-
sortia. (A) E. faecalis strain V583 and (B) OG1X after growth in monoculture
or with added healthy human fecal flora were enumerated on Bile Esculin
Azide agar containing antibiotics as appropriate. All cultures were per-
formed in triplicate, and error bars represent the SD of the mean. NANA,
N-acetylneuraminic acid.
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[using pTEF2Spc (30) to provide a selectable spectinomycin
resistance marker] were reintroduced into V19 (or as a control,
introduced into OG1RF). V19(pTEF1) did not show susceptibility
to coculture-mediated inhibition, but V19(pTEF2Spc) was found
to be highly susceptible (Fig. 3B).
Whereas OG1RF and Pan7 were able to kill V583 or V19(pTEF2),
transconjugants OG1RF(pTEF2) and Pan7(pTEF2) had lost
the ability to induce killing (Fig. 3C). The plasmid acquisition-
dependent loss of effector/killing activity was reminiscent of the
known plasmid acquisition-associated loss of pheromone pro-
duction by E. faecalis (32–34). If pTEF2 suppressed expression of
the killing factor in a manner analogous to suppression of phero-
mone production in its host, then it stood to reason that the plas-
mid-free variant of V583 lacking pTEF2, strain V19, itself might
now be capable of killing V583. We found that this was, in fact,
the case (Fig. 3D). Interestingly, unlike the V19(pTEF2) trans-
conjugant, OG1RF(pTEF2) and Pan7(pTEF2) remained resistant
to killing (SI Materials and Methods and Fig. S1). This observation
suggested that pTEF2 contributed to susceptibility but by itself, was
insufficient to completely confer the susceptible phenotype.
pTEF2-Dependent Killing Is Mediated by a Pheromone. Enterococcal
pheromones are generated by processing and release of short
lipoprotein signal peptide fragments (33, 35). One step in the
processing is mediated by membrane metalloprotease Eep
(35). If pheromone production by Pan7 and other commensal
E. faecalis was involved in killing, then an eep mutant should be
defective as an effector/killing strain. In fact, E. faecalis FA2-
2Δeep (36) showed partially diminished killing of V583 (Fig. 4A).
In a screen of mariner IS mutants in FA2-2 for loss of killing
activity, an additional mutant was found that possessed a trans-
poson IS in ORF EF0688 as recently reported (37). This mutant
was even more defective in killing than the eep mutant, suggesting
that the putative ATP binding cassette transporter was involved in
the pheromone production pathway. Because ef0688 and ef0689
were predicted to reside on the same transcript, a specific deletion
of reading frames EF0688 and EF0689 was generated, FA2-
2ΔpptAB, and verified as having a more than fivefold decrease
in killing activity (Fig. 4A).
The known pheromone receptors TraC and PrgZ, which are
encoded on pheromone-responsive plasmids pAD1 (38) and
pCF10 (39), specifically bind and facilitate pheromone uptake
(40). A homolog was identified by BLASTP (41) on pTEF2
EFB0004 (traC-2)]. To test its role in conferring the susceptibility
phenotype, we constructed an in-frame deletion of traC-2 in
pTEF2 in V583. As predicted, the traC-2 null mutant showed
decreased susceptibility to Pan7 killing (Fig. 4A), further impli-
cating pheromones.
Identification of the Effector Pheromone.To identify the hypothetical
pheromone responsible for killing, we developed a library of
synthetic peptides corresponding to all predicted pheromone se-
quences inferred from the E. faecalis genome sequence (13).
Pheromone peptides are derived from the seven to nine amino
acids preceding the signal peptide cleavage site cysteine of lipo-
proteins (35, 42). Based on the V583 genome (13), 81 oligopep-
tides inferred from lipoprotein leader sequences were synthe-
sized (Table S1) and tested for inhibition of V583. Three inhibited
V583 and also, V19 in a pTEF2-dependent manner (Fig. 4B). One
in particular (NH3-VAVLVLGA-COOH) possessed activity in
picomolar concentrations, being >106-fold more active than the
only other two and showing inhibitory activity. This highly active
peptide matched a pheromone previously identified as cOB1
(43). To confirm that cOB1 was responsible for inhibition of V583,
the sequence was scrambled, retested, and found to have lost all
inhibitory activity (Table S1). To confirm that cOB1 production by
the effector strain was responsible for killing, the precursor lipo-
protein encoding cOB1, ef2496, was deleted from the chromo-
some of E. faecalis FA2-2. As predicted, FA2-2Δef2496 lost the
ability to inhibit V583 (Fig. 4A), and the inhibitory phenotype was
restored by repair of the ef2496 reading frame, (Fig. 4A), proving
Fig. 2. Commensal enterococci kill MDR E. faecalis
V583. (A) Preculture of the fecal consortium in vary-
ing levels of erythromycin eliminated the ability of
the fecal consortium to kill V583. (B) Erythromycin
pretreatment of the fecal consortium also eliminated
native enterococci from the consortium, whereas
Enterobacteriaceae remained relatively unchanged.
(C) Tetracycline pretreatment of the fecal consortium
does not eliminate V583 killing and enhances killing,
even in the absence of added galactose. (D) Tetracy-
cline pretreatment of the fecal consortium enriched
the presence of native enterococci in the consortium
and inhibited Enterobacteriaceae, showing that they
are not involved in V583 elimination and suggesting
that the former may be involved. (E) Three com-
mensal E. faecalis strains (OG1RF, FA2-2, and Pan7;
isolated from the healthy fecal consortium) induce
zones of clearing in lawns of V583. (F) Deletion of
rpoN in the chromosome of V583 does not affect
susceptibility to killing by commensal enterococci, such
as Pan7.









that cOB1 production by the effector was necessary and sufficient
to mediate V583 killing.
Identification of the Second V583 Locus Required for the Susceptible
Phenotype. Identification of a heptapeptide that inhibited V583 gave
us a tool to isolate cOB1-resistant mutants of V583. To ensure that
resistance did not derive from the simple curing of pTEF2, a chlor-
amphenicol-resistant derivative of pTEF2 (pTEF2Cm) (30) was
introduced into plasmid-cured strain V19. As shown in Fig. 4B, cOB1-
resistant mutants, selected in the presence of 15 μg/mL chloram-
phenicol, occurred at an unexpectedly high frequency of 2.4 × 10−6.
One arbitrarily selected mutant, V19(pTEF2)pheromone-resistant (PR),
was subcultured in the absence of cOB1 selection and found to be
stably resistant to cOB1 killing. The genome of V19(pTEF2)PR was
sequenced and aligned to V583 (13). The main difference was
excision from the mutant of a 32,719-bp IS-like element annotated
as a plasmid remnant (base pairs 131,647–164,366 encompassing
ORFs EF0127 to EF0166) (Fig. S2) (17). This region includes
genes predicted to encode a relaxase (EF0143), recombinase
(EF0166), surface exclusion protein (EF0146), and aggregation
substance (EF0149) along with a number of conserved hypothetical
Fig. 3. Both killing and susceptibility to killing relate to the presence of pTEF2.
(A) Zone of inhibition around E. faecalis Pan7 on V583 but not lawns of OG1RF/
V583 hybrids containing the 138-kb V583 PAI and 147- (Tc3) or 720-kb (Tc12)
additional flanking V583 chromosomal DNA in the OG1RF background.
(B) Killing by fecal isolate Pan7 requires the presence of pTEF2 in the genetic
background provided by the plasmid-cured V583 derivative, strain V19. A second
pheromone-responsive plasmid present in V583, pTEF1, does not render V19
susceptible to killing. (C) In addition to conferring susceptibility to killing in V19,
pTEF2 but not pTEF1, when transferred into commensal strain Pan7, inhibits its
ability to kill V583. (D) Moreover, V19 (V583 cured of plasmids) becomes capable
of killing V583, but that ability is lost on reacquisition of pTEF2.
Fig. 4. V583 killing is mediated by production of pheromone cOB1 by com-
mensal strains. (A) WT plasmid-free strain FA2-2 is capable of killing V583. This
ability is reduced in a mutant strain defective in a membrane protease involved in
processing lipoprotein signal peptides into pheromones (eep). It is nearly com-
pletely eliminated in a mutant lacking a new putative ATP binding cassette
transporter encoded by pptAB (37). FA2-2, in which the gene encoding the lipo-
protein that gives rise to pheromone cOB1, ef2496, is deleted, is no longer able to
kill V583. This ability is restored in revertant FA2-2Ωef2496. Deleting putative
pheromone receptor traC2 from pTEF2 in V583 eliminates it susceptibility to kill-
ing, further implicating a pheromone. (B) Purified cOB1 pheromone (VAVLVLGA)
specifically inhibits V583 [with an MIC (minimum inhibitory concentration) of
25 pM] but not its plasmid cured derivative V19. Of 81 pheromone peptides
tested, only 2 others showed detectable activity with MICs ∼106-fold higher
than the MIC of cOB1. Susceptibility to pheromone killing was restored in V19 by
the return of pTEF2. (Inset) Resistant V19(pTEF2) mutants, such as V19(pTEF2)PR,
were readily obtained in the zones of clearing in lawns exposed to cOB1.
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proteins. An identical deletion was observed in 10 independently
obtained resistant mutants.
Other E. faecalis Strains Harbor Portions of the IS-Like Element That
Correlates with Susceptibility to cOB1. We recently generated a
large number of draft genome sequences for a diverse collection of
E. faecalis (https://olive.broadinstitute.org/projects/work_package_6)
and queried them for integration of an element similar to that
lost by V19(pTEF2)PR. Thirteen E. faecalis strains of diverse
multilocus sequence types possessed varying portions. Plasmid
pTEF2Cm was introduced into each strain by filter mating, and
10 became sensitive to the cOB1 pheromone. Alignment of the
genomes of the pheromone-susceptible and -nonsusceptible
isolates (Fig. S3) allowed us to narrow the region of the inserted
element that sensitizes a strain to pheromone-mediated killing in
the presence of pTEF2. All cOB1-susceptible strains possessed
at least genes EF0151–EF0165, implicating them or sequences
encompassed in the cOB1 susceptibility phenotype. Direct de-
letion of DNA encoding EF0143–EF0160 rendered V583 resistant
to cOB1 killing (Fig. S4), further narrowing the genes involved.
Specific deletion of either a putative relaxase (EF0143) or a pu-
tative amidase (EF0160), however, did not confer resistance.
Discussion
Little is actually known about the nature of Enterococcus exis-
tence in native ecologies. In hospitals, patients acquire MDR
E. faecalis and Enterococcus faecium in their GI tract consortia after
admission, mainly from contaminated surfaces (6). Colonization
is facilitated by destabilization of the patient’s native microbiota
by antibiotic treatment, a main predisposing factor (6). A few
orally acquired cells are well-positioned to greatly expand into
antibiotic-vacated habitats of the gut, which serves as a staging
ground for infection. The precise nature of the food web in which
the auxotrophic needs are satisfied for either commensal entero-
cocci or hospital-endemic MDR strains is currently unknown.
Understanding the fundamental principles of colonization could
provide new insights for preventing downstream, antibiotic refractory
infection.
We found that prototype MDR E. faecalis V583 possessed
limited ability to grow in a consortium of GI tract flora that in-
cluded commensal enterococci. The incompatibility between
V583 and commensal enterococci was traced to the production
by commensal strains of the heptapeptide pheromone, cOB1,
which induced lethal cross-talk between mobile elements resi-
dent in V583–plasmid pTEF2 and an IS-like element resident
within the chromosome (Fig. 5). This incompatibility suggests
that the accretion of these elements by V583 occurred in the
relative absence of commensal enterococci. The susceptibility of
V583 to killing by commensal strains provides strong evidence
that they rarely occur in the same niche and that V583 has pro-
liferated in habitats in which commensal strains are excluded—
because of nutritional requirements, lack of colonization traits,
such as those encoded by the PAI, or antibiotic elimination.
The precise mechanism for cOB1 killing of V583 is the subject
of ongoing study. Microarray experiments found high levels of
cOB1-mediated induction (>100-fold) of many pTEF2 genes
related to conjugal transfer and little change in chromosomal
gene expression (Tables S2 and S3), giving no obvious clue to the
interactions between pTEF2 and the chromosomally integrated
IS-like element that is necessary for susceptibility. Recent work
from the laboratory of Menard and Grossman (44) has shown
that imprecise excision of the Bacillus subtilis integrative and
conjugative element, ICEBs1, from nonpreferred sites of in-
tegration leads to a loss in cell viability. The element studied
here shares properties with ICEBs1, including terminal repeats
and genes related to movement. The fact that its imprecise ex-
cision may somehow be triggered in trans by pheromone-induced
gene products of pTEF2 seems likely. However, we showed that
this hypothetical excision is not mediated by the relaxase en-
coded within the IS-like element, EF0143, or the pTEF2 relaxase
mutated in a previous study (30), because both mutants are
sensitive to pheromone inhibition. It seems that other proteins
encoded by pTEF2 act in trans to volatilize the chromosomal IS-
like element on cOB1 induction or otherwise, result in effects
that are toxic to the cell (Fig. 5).
Irrespective of mechanism, the incompatibility between V583
and commensal strains of E. faecalis provides clear support for the
hypothesis that this MDR hospital strain and commensal entero-
cocci do not occupy the same habitat (20) and begins to shed light
on differences in the colonization properties of hospital and
commensal lineages of enterococci. This incompatibility highlights
the opportunity for therapies that preserve native enterococcal
flora as a barrier to colonization by such hospital-adapted lineages.
Materials and Methods
Bacterial Strains and Growth of Enterococci in Fecal Consortia. Fecal samples
from healthy volunteers were obtained and pooled using an institutional
review board-approved protocol. Pan7, a nonhemolytic, tetracycline-resistant
E. faecalis strain speciated by 16S rDNA sequence, was the most abundant
Enterococcus in the pooled fecal consortium. Other strains used in this study
are listed in Table S4. To approximate cues that occur in the GI tract, a
medium was developed that included a commercially available crude extract
of HGM (Pfaltz & Bauer); 1% HGM9 was made by dissolving 1% (wt/vol)
HGM in Davis minimal medium (24), pH 7.5. E. faecalis and fecal bacteria
were grown in 1% HGM9 at 37 °C without shaking. A layer of autoclaved
light mineral oil (Fisher Scientific) was added to cultures containing fecal
bacteria to limit oxygenation.
Fitness of V583 and Mutants Assessed in Coculture. The effect of fecal flora on
growth and proliferation of V583 was determined in 1% HGM9. Various
carbohydrates were added to induce population shifts within the fecal
population. Details of the coculture assay are provided in SI Materials
and Methods.
Fig. 5. Model for pheromone killing of V583. (1) Pheromones expressed by
plasmid-free commensal E. faecalis are encoded within the signal peptide of
lipoproteins, such as EF2496, which contain within the precursor sequence
pheromone cOB1 (red wavy line). The signal peptides are processed, in part,
by membrane protease Eep and pumped into the medium by a putative ATP
binding transporter, PptAB, discovered here to our knowledge (more details
in ref. 37). Functions shown in this work to contribute to the killing and
susceptible phenotypes are identified by ✓. Enrichment of commensal en-
terococci in the fecal consortium (for example, by suppression of competitive
microbes with tetracycline) enhanced V583 killing. (2) TraC2, a homolog to
known pheromone receptors, presumably facilitates uptake of the cOB1
pheromone identified here as the killing effector molecule produced by
commensal enterococci. (3) The main effect of cOB1 on V583 is to specifically
induce transcription of plasmid pTEF2 genes over 100-fold. Cross-talk be-
tween the induced genes and an essential IS-like element on the chromo-
some of V583 and a number of other MDR E. faecalis strains resulted in V583
killing. All spontaneously resistant mutants of V583 had spontaneously lost
the IS-like element.









Assessment of Killing Activity of Purified Peptides. Soft agar overlay assays
were used to screen and visualize killing of various E. faecalis strains by
commensal enterococci or purified pheromones as described in SI Materials
and Methods. V19(pTEF2), which showed the greatest sensitivity, was used
in soft agar overlays to detect inhibition by purified pheromones. The 81
theorized pheromone peptides were synthesized initially at >75% purity
(Lifetein, LLC) and resuspended in acetonitrile. Peptides exhibiting inhibitory
activity were resynthesized and HPLC-purified to >95% purity. Inhibitory
activity was determined as a visible zone of clearing affected by where 1 μL
1-mg/mL solution of the peptide was placed. To determine comparative
activities of peptides exhibiting activity, highly purified peptides were diluted
twofold in acetonitrile, and 1-μL aliquots of each dilution were again spotted
on the top agar lawn.
Generation of traC-2, EF0143, EF0160, and EF0143–EF0160 Deletion Mutants in V583
and Deletion of EF2496 in FA2-2. Deletion of most of the coding sequences of
traC-2, EF0143, EF0160, and EF2496 in strain FA2-2, generating in-frame fusions
of sequences near the start and stop codons of each, minimized polar effects
essentially as described (45). A similar approach was used to delete sequences
spanning from EF0143 to EF0160. Primers used for the construction of plasmid
deletion constructs are listed in Table S5, and detailed information on con-
struction of mutants is provided in SI Materials and Methods.
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